like I said te virbrac trial was substandard at best they did a quick cheap and nasty field trial they didn’t get the desired results and then they decided to stop spending money on it and move on they didn’t re-try or re-calibrate the mixture
moving on
BGt has been in deep talks with multiple big agricultural companies with multiple billion dollar market caps they have signed non disclosure agreements so they can’t be named at this stage
they are currently doing in-house testing and BGT is waiting for this process to be completed
management could potentially give us all an update on progress and where everything is currently standing
we wait with a potential new mode of action which the global agricultural market needs with $5.3 million in cash $12 million market cap so cheap ....
the last new mode of action that hit the market was in 2008 and is currently generating $1.2 billion dollars in sales annually $$$
BGT Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
